ARCHIVES

Blood Donors With Undertrain HTLV-3 Should Be Notified, Consensus Panel Says

This article is from The Cancer Letter archive.

Vol. 12 No. 29 | July 18, 1986

Download PDF Visit The Full Archive

Related Articles

US Oncology Begins Trial Of Taxotere And Xeloda

September 27, 2002

Women With Least Aggressive Subtype of Breast Cancer Still at Risk After 10 Years

September 28, 2012

CTEP-Approved Trials For the Month of June

June 28, 2013

OD Contract Concepts Okayed

October 17, 1986

FDA To Once Again Review ESA Label To Reflect Results Of Negative Studies.

December 7, 2007

President, Congress, Cancer Letter Take Off

August 22, 1986